Searchable abstracts of presentations at key conferences in endocrinology

ea0041gp150 | Pituitary - Clinical | ECE2016

Treatment of acromegaly increases BMD but reduces Trabecular Bone Score – a longitudinal study

Godang Kristin , Cristina Olarescu Nicoleta , Bollerslev Jens , Heck Ansgar

Background: Bone turnover is increased in active acromegaly. Despite normalization of bone turnover after treatment, the risk for vertebral fractures remains increased. Gonadal status, but not bone mineral density (BMD) is correlated to vertebral fracture incidence. Trabecular and cortical bone are differentially affected by GH and IGF-1. The trabecular bone score (TBS) is related to bone microarchitecture and provides further information not captured by BMD measurement.<p...

ea0099p313 | Pituitary and Neuroendocrinology | ECE2024

TGFBR3L gene expression and relevance for the gonadotroph non-functioning pituitary neuroendocrine tumours

Wessel Maren , Petter Berg Jens , Bollerslev Jens , Cristina Olarescu Nicoleta

Objective: Transforming growth factor beta receptor 3 like (TGFBR3L) has been recently described as a pituitary-specific membrane protein detected in a proportion of the gonadotroph cells in non-neoplastic and tumour tissue (1). Furthermore, mouse studies have indicated that TGFBR3L is an inhibin B co-receptor that regulates FSH levels (2). We hypothesized that TGFBR3L expression in gonadotroph non-functioning pituitary neuroendocrine tumours (NF-PitNETs) is related to clinica...

ea0073oc8.6 | Oral Communications 8: Pituitary and Neuroendocrinology | ECE2021

Increased PCSK1N in silent corticotroph pituitary adenomas may explain their “silence”

Ringvoll Normann Kjersti , Kristin Berland Astrid Berland , Olsen Linn Guro , Lekva Tove , Dahlberg Daniel , Bollerslev Jens , Petter Berg Jens , Cristina Olarescu Nicoleta

BackgroundCorticotroph pituitary adenomas present different degrees of functionality, from silent to whispering and finally to functioning adenomas leading to Cushing’s disease. Compared to their functioning (FCA) counterpart, the silent corticotroph adenomas (SCA) express lower levels of the corticotroph cell lineage marker–TBX19 (TPIT), proopiomelanocortin (POMC), and prohormone converting enzyme 1/3 (PC1/3, PCSK1)–t...